Neumora Therapeutics, Stock Investor Sentiment
| NMRA Stock | 1.13 0.03 2.59% |
About 86 percent of Neumora Therapeutics,'s investors are aggressively looking to sell. The analysis of overall sentiment of trading Neumora Therapeutics, stock suggests that a very large number of investors are panicking at this time. The current market sentiment, together with Neumora Therapeutics,'s historical and current headlines, can help investors time the market. In addition, many technical investors use Neumora Therapeutics, stock news signals to limit their universe of possible portfolio assets.
Comfort Level 14
Terrified
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Neumora Therapeutics,'s input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Neumora Therapeutics,.
News SentimentBearish | Hype SentimentBearish | Insider SentimentDisposing |
Neumora Historical Sentiment
Although Neumora Therapeutics,'s investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Neumora, such as negative comments on social media and news outlets, may cause fear in the market and push Neumora Therapeutics,'s investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Neumora.
Neumora |
Neumora Therapeutics, Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Neumora Therapeutics, can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Neumora Therapeutics, Historical Investor Sentiment
Investor biases related to Neumora Therapeutics,'s public news can be used to forecast risks associated with an investment in Neumora. The trend in average sentiment can be used to explain how an investor holding Neumora can time the market purely based on public headlines and social activities around Neumora Therapeutics,. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Neumora Therapeutics,'s market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Neumora Therapeutics, and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Neumora Therapeutics, news discussions. The higher the estimate score, the more favorable the investor's outlook on Neumora Therapeutics,.
Far too much social signal, news, headlines, and media speculation about Neumora Therapeutics, that are available to investors today. That information is available publicly through Neumora media outlets and privately through word of mouth or via Neumora internal channels. However, regardless of the origin, that massive amount of Neumora data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Neumora Therapeutics, news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Neumora Therapeutics, relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Neumora Therapeutics,'s headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Neumora Therapeutics, alpha.
Neumora Therapeutics, Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Disposition of 133097 shares by Paul Berns of Neumora Therapeutics, subject to Rule 16b-3 | 12/27/2024 |
2 | Acquisition by Burow Kristina of 1176593 shares of Neumora Therapeutics, subject to Rule 16b-3 | 01/31/2025 |
3 | NMRA INVESTOR DEADLINE Robbins Geller Rudman Dowd LLP Announces that Neumora ... | 02/24/2025 |
4 | Levi Korsinsky Notifies Neumora Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline NMRA | 03/07/2025 |
5 | INVESTOR ALERT Faruqi Faruqi, LLP Investigates Claims on Behalf of Investors of Neumora Therapeutics | 03/11/2025 |
6 | Lead Plaintiff Deadline Approaching in NMRA Kessler Topaz Meltzer Check, LLP Reminds Investors a Securities Fraud Class Action Has Been Filed Against Neumora Th... | 03/13/2025 |
7 | ROSEN, THE FIRST FILING FIRM, Encourages Neumora Therapeutics, Inc. ... | 03/14/2025 |
8 | NMRA SHAREHOLDER ALERT Kessler Topaz Meltzer Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Neumora Therapeutics, Inc. | 03/17/2025 |
9 | Class Action Filed Against Neumora Therapeutics, Inc. Seeking Recovery for Investors Contact Levi Korsinsky | 03/18/2025 |
10 | ONGOING DEADLINE ALERT Faruqi Faruqi, LLP Investigates Claims on Behalf of Investors of ... | 03/19/2025 |
11 | Neumora Therapeutics, Inc. Class Action The Gross Law Firm Reminds Neumora Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintif... | 03/20/2025 |
Complementary Tools for Neumora Stock analysis
When running Neumora Therapeutics,'s price analysis, check to measure Neumora Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neumora Therapeutics, is operating at the current time. Most of Neumora Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Neumora Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neumora Therapeutics,'s price. Additionally, you may evaluate how the addition of Neumora Therapeutics, to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |